Science Resources RSS Feeds
|
 |
 |
 |
| View Larger Image | Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy | Hardcoverby Dieter Marmé (Author), Dieter Marmé (Editor), Norbert Fusenig (Editor)
| List Price: | $379.00 | | | Available: | Usually ships in 24 hours |
| | Binding: | Hardcover | | Publisher: | Springer | | Edition: | 1st Edition | | Page Count: | 845 Pages | | Publication Date: | December 06, 2007 | | Sales Rank: | 2,081,207nd |
|
EDITORIAL REVIEWS |
Product Description
Tumor angiogenesis is one of the most prominent mechanisms driving tumor development and progression. In the past 30 years some of the most important signaling pathways linking specific angiogenic activities of tumor cells to fatal reactions of the patient s vascular system have been elucidated. Crucial targets for therapeutic intervention have been identified and validated. Based on these achievements targeted drug development programs have been implemented to interfere with tumor angiogenesis as an attractive strategy in cancer treatment. The first targeted anti-angiogenic drugs have been approved for a variety of solid metastasizing cancers. Part 1 describes the basic mechanisms. Tumor-angiogenic signaling pathways are presented as new potential targets for anti-angiogenic therapy. Part 2 reviews the efforts made to validate new targets and to show efficacy in animals. Part 3 is devoted to the clinical development of the novel anti-angiogenic drugs and their use in clinical practice. |
SIMILAR PRODUCTS |
| DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology (Cancer: Principles & Practice (DeVita)(2 Volume Set)
by Vincent T DeVita (Author), Theodore S Lawrence (Author), Steven A Rosenberg (Author), Ronald A DePinho (Editor), Robert A Weinberg (Editor)
Acclaimed by the worldwide medical community as "a staple reference text in the medical oncologist's library" (JAMA), DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology is now in its Eighth Edition. This edition is in full color for the first time, has a new editor, Theodore S. Lawrence, MD, PhD, a radiation oncologist, and has two Associate Scientific Advisors, Ronald A. DePinho, MD and Robert A. Weinberg, PhD, with special expertise in molecular biology. More than 40...
| 
| Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization
by Edward Kerns (Author), Li Di (Author)
Of the thousands of novel compounds that a drug discovery project team invents and that bind to the therapeutic target, typically only a fraction of these have sufficient ADME/Tox properties to become a drug product. Understanding ADME/Tox is critical for all drug researchers, owing to its increasing importance in advancing high quality candidates to clinical studies and the processes of drug discovery. If the properties are weak, the candidate will have a high risk of failure or be less...
|
|
|
|
